{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:26:24Z","timestamp":1694067984139},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"DOI":"10.1111\/bjd.14174","type":"journal-article","created":{"date-parts":[[2015,9,19]],"date-time":"2015-09-19T12:02:42Z","timestamp":1442664162000},"page":"652-653","source":"Crossref","is-referenced-by-count":4,"title":["Decreased expression of ten-eleven translocation 2 protein is associated with progressive disease and death in patients with mycosis fungoides"],"prefix":"10.1093","volume":"174","author":[{"given":"T.","family":"Gambichler","sequence":"first","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Mamali","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Patsinakidis","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Moritz","sequence":"additional","affiliation":[{"name":"Department of Dermatology University Hospital of M\u00fcnster M\u00fcnster Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mucke","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Skrygan","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Stockfleth","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"St\u00fccker","sequence":"additional","affiliation":[{"name":"Department of Dermatology Ruhr-University Bochum Gudrunstra\u00dfe 56 44791 Bochum Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/cas.12484","article-title":"TET2 as an epigenetic master regulator for normal and malignant haematopoiesis","volume":"105","author":"Nakajima","year":"2014","journal-title":"Cancer Sci"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1002\/iub.1389","article-title":"The TET2 interactors and their links to hematological malignancies","volume":"67","author":"Pan","year":"2015","journal-title":"IUBMB Life"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3109\/10428194.2013.778408","article-title":"Decreased 5-hydroxymethylcytosine levels are associated with TET2 mutation and unfavorable overall survival in myelodysplastic syndromes","volume":"54","author":"Liu","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1200\/JCO.2005.11.353","article-title":"Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73","volume":"23","author":"van Doorn","year":"2005","journal-title":"J Clin Oncol"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CMR.0b013e32835f9bd4","article-title":"Loss of 5-hydroxymethylcytosine and ten-eleven translocation 2 protein expression in malignant melanoma","volume":"23","author":"Gambichler","year":"2013","journal-title":"Melanoma Res"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.ygeno.2014.08.017","article-title":"Loss of 5-hydroxymethylcytosine in cancer: cause or consequence?","volume":"104","author":"Ficz","year":"2014","journal-title":"Genomics"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and S\u00e9zary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-genet-110711-155451","article-title":"5-Methylcytosine DNA demethylation: more than losing a methyl group","volume":"46","author":"Franchini","year":"2012","journal-title":"Annu Rev Genet"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/ni.3148","article-title":"TET1 is a tumor suppressor of hematopoietic malignancy","volume":"16","author":"Cimmino","year":"2015","journal-title":"Nat Immunol"},{"key":"2023033115535081700_","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/cup.12411","article-title":"Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders","volume":"41","author":"De Souza","year":"2014","journal-title":"J Cutan Pathol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.14174","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/174\/3\/652\/49716333\/bjd0652.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/174\/3\/652\/49716333\/bjd0652.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T09:09:50Z","timestamp":1692004190000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/174\/3\/652\/6617157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":12,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.14174","relation":{},"ISSN":["1365-2133","0007-0963"],"issn-type":[{"value":"1365-2133","type":"electronic"},{"value":"0007-0963","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,3,1]]},"published":{"date-parts":[[2016,3,1]]}}}